Home > Boards > US Listed > Medical - Drugs > Catabasis Pharmaceuticals (CATB)

Back on Oct 20 (I think) I read

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
K The New Investor Member Profile
 
Followed By 1
Posts 13
Boards Moderated 0
Alias Born 07/28/16
160x600 placeholder
Catabasis Pharmaceuticals to Present at Upcoming Virtual Investor Conferences Business Wire - 9/8/2020 8:00:00 AM
Catabasis Pharmaceuticals to Host Virtual KOL Event on Edasalonexent and Duchenne Muscular Dystrophy Business Wire - 9/2/2020 8:00:00 AM
Catabasis Pharmaceuticals Reports Second Quarter 2020 Financial Results and Reviews Business Progress Business Wire - 8/10/2020 4:10:00 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 8/10/2020 4:01:26 PM
Catabasis Pharmaceuticals to Present at Virtual 2020 Wedbush PacGrow Healthcare Conference Business Wire - 8/5/2020 8:00:00 AM
Catabasis Pharmaceuticals & Bill & Melinda Gates Medical Research Institute to Study CAT-5571 in Drug-Sensitive & Drug-Resist... Business Wire - 8/4/2020 8:00:00 AM
Catabasis Pharmaceuticals to Report Second Quarter 2020 Financial Results on Monday, August 10th Business Wire - 7/27/2020 8:00:00 AM
Catabasis Pharmaceuticals to Present at Parent Project Muscular Dystrophy Virtual Annual Conference Business Wire - 7/15/2020 8:00:00 AM
 Catabasis Joins Russell 3000® Index Business Wire - 6/29/2020 4:10:00 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/12/2020 11:57:04 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/12/2020 11:46:47 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/12/2020 11:45:58 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/12/2020 11:45:24 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/12/2020 11:34:43 AM
Securities Registration: Employee Benefit Plan (s-8) Edgar (US Regulatory) - 6/12/2020 8:12:53 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/12/2020 8:10:59 AM
Catabasis Pharmaceuticals Names Ben Harshbarger Senior Vice President, General Counsel Business Wire - 6/12/2020 8:00:00 AM
Catabasis Pharmaceuticals Reports First Quarter 2020 Financial Results and Reviews Business Progress Business Wire - 5/12/2020 4:10:00 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 5/12/2020 4:02:14 PM
Catabasis Pharmaceuticals Presents Edasalonexent, a Potential Foundational Therapy for Duchenne Muscular Dystrophy Business Wire - 5/12/2020 8:00:00 AM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 4/28/2020 4:11:47 PM
Proxy Statement (definitive) (def 14a) Edgar (US Regulatory) - 4/28/2020 4:06:40 PM
Catabasis Pharmaceuticals to Report First Quarter 2020 Financial Results on Tuesday, May 12th Business Wire - 4/28/2020 8:00:00 AM
Catabasis Pharmaceuticals to Present at 2020 Muscular Dystrophy Association Virtual Poster Session Business Wire - 4/17/2020 8:00:00 AM
Catabasis Pharmaceuticals to Present at the Upcoming 2020 Solebury Trout Virtual Investor Conference Business Wire - 3/25/2020 8:00:00 AM
K The New Investor   Friday, 10/28/16 10:50:31 AM
Re: Dr_Thorfin post# 41
Post # of 221 
Back on Oct 20 (I think) I read it would take 11 days for shorts to cover, so I expect it would drop until Nov 1, but maybe it will stay down until after election....GLTA!

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences